To assess the effect of exogenous oxytocin on the static component of BPH, an immortalised and two primary derived prostate fibroblasts were exposed to oxytocin at increasing concentrations [0.1 nM–1 μM]. This evidence concerns the gene OXT and benign prostatic hyperplasia.